BioNTech SE

NASDAQ: BNTX
$218.17
-$2.41 (-1.1%)
Closing price June 15, 2021

BioNTech, Exelixis, Foot Locker and More Tuesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Chris Lange
29 days ago

Earnings Previews: BioNTech, Coty, Duke Energy, Workhorse
After a quiet Friday afternoon, March quarter earnings hit the ground running again before markets open Monday. More than 1,500 earnings reports are expected next week.
Paul Ausick
1 month ago

Best Earnings Reports for Week Ending April 2, 2021
Here are five stocks that reported earnings in the past week and all posted better-than-expected numbers and investors rewarded them with higher share prices.
Paul Ausick
2 months ago

Earnings Previews: Canoo, BioNTech
Two interesting earnings reports are due early next week. One is recent entry in the electric vehicle market and the other is a co-developer of a COVID-19 vaccine.
Paul Ausick
2 months ago

Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
Chris Lange
6 months ago

COVID-19 Vaccines Are on the Way and Major Players Are Cashing In
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
Chris Lange
6 months ago

Top Analyst Upgrades and Downgrades: BioNTech, FedEx, First Solar, Micron, MP Materials, Nio, Occidental, Salesforce, Schwab, Square, Zoom Video and More
Tuesday's top analyst upgrades and downgrades included BioNTech, Charles Schwab, FedEx, First Solar, Micron Technologies, Nio, Occidental Petroleum, Salesforce.com, Square and Zoom Video...
Jon C. Ogg
6 months ago
Last Updated: 6 months ago

With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Chris Lange
6 months ago

Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial
Shares of COVID-19 vaccine duo Pfizer and BioNTech made handy gains on Wednesday after they announced their late-stage coronavirus study had concluded.
Chris Lange
6 months ago

Moderna's COVID-19 Vaccine Results Lift Blue Chips
Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90% efficacy in the past week.
Paul Ausick
7 months ago

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market
Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.
Chris Lange
7 months ago

Did Regeneron Just Revive Hopes About Beating COVID-19?
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe, more...
Jon C. Ogg
7 months ago

What's the Next Step for Pfizer and BioNTech's Coronavirus Vaccine?
While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s CEO has provided an update on their COVID-19 vaccine.
Chris Lange
8 months ago

Top Analyst Upgrades and Downgrades: Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton, Salesforce, Williams-Sonoma and More
Wednesday's top analyst upgrades and downgrades included Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton Interactive, Salesforce.com and Williams-Sonoma.
Jon C. Ogg
8 months ago
Last Updated: 8 months ago

Are President Trump's COVID-19 Drugs the Real Winners in the Race?
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Jon C. Ogg
8 months ago
Last Updated: 8 months ago